Human antibodies which bond human IL12 and methods for producing them

Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VENTURINI AMY, TRACEY DANIEL E, KAYMAKCALAN ZEHRA, VELDMAN GEERTRUIDA M, WIDOM ANGELA, DUNCAN ALEXANDER R, WHITE MICHAEL, SMITH STEPHEN, SAKORAFAS PAUL, DU FOU SARAH L, MYLES ANGELA, FRIEDRICH STUART, ROGUSKA MICHAEL, ELVIN JOHN G, SALFELD JOCHEN, PASKIND MICHAEL, LABKOVSKY BORIS, DERBYSHIRE ELAINE J, BANERJEE SUBHASHIS, WARNE NICHOLAS W, CARMEN SARA, HOLTET THOR LAS
Format: Patent
Sprache:eng ; pol
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the inveniton are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.